Clinical Trial Update: Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD [NA]

View source ↗

Summary

A completed clinical trial evaluated whether omega-3 fatty acid supplementation influences vitreous VEGF levels in wet age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• Omega-3 fatty acids supplement (Omega-3 fatty acids)

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Exudative Age Related Macular Degeneration | NA | Status: COMPLETED | Results posted: 2013-06-17